Bladder Cancer
Conditions
Keywords
Quality of Life, Bladder Cancer, Late effects
Brief summary
Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.
Interventions
None listed
Sponsors
Aarhus University Hospital
University of Aarhus
National Research Center for Survivorship and Late Adverse Effects Following Pelvic Organ Cancer, Denmark
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023 * Ability to understand written and oral Danish
Exclusion criteria
* Known Alzheimers disease * Diagnosed other causes explaining the hematuria
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Health-related Quality of Life | 5 years from baseline inclusion | Changes in Quality of Life measured using validated instruments |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of late effects | 5 years from baseline inclusion | Based on Patient Reported Outcomes and medical records |
Countries
Denmark
Contacts
PRINCIPAL_INVESTIGATORJørgen Bjerggaard Jensen, Professor
Department of Urology, Aarhus University Hospital
Outcome results
None listed